Pharmafile Logo
Pharmafocus logo
Advanced Search

COVID-19

Showing 15 posts of 602 posts found.

Arthritis drugs could save lives of COVID-19 patients, study finds

January 8, 2021
Medical Communications COVID-19

Two drugs used to treat rheumatoid arthritis could cut COVID-19 hospital stays by as much as 10 days, and save …

News
mcr_glasgow

New COVID-19 screening hub to be established in Scotland

January 7, 2021
COVID-19

A new COVID-19 drug screening and resistance hub, funded by medical research charity LifeArc and the Medical Research Council, is …

News
sputnik-v-covid-19-vaccine-scaled-e1599484511213

Bolivia registers Russia’s Sputnik V COVID-19 vaccine

January 7, 2021
COVID-19, Vaccine

Bolivia’s state agency for medicines and health technologies (AGEMED) has registered Russia’s Sputnik V COVID-19 vaccine under emergency use authorisation. …

News
moderna_norwood_plant

EU approves Moderna’s COVID-19 vaccine

January 7, 2021
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine

The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 6, 2021
Research and Development COVID-19, Vaccine

In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …

News
who_flag

WHO recommends against 12-week delay for COVID-19 vaccine doses

January 6, 2021
Research and Development COVID-19, Vaccine, WHO

The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …

News
static

Israel authorises Moderna’s COVID-19 vaccine for use

January 5, 2021
Manufacturing and Production COVID-19, Moderna, Vaccine

Moderna has announced that Israel’s Ministry of Health (MOH) has authorised the use of its COVID-19 vaccine. Israel has secured …

News

Emergex to collaborate with Bio-Manguinhos on new COVID-19 vaccine

January 5, 2021
Manufacturing and Production COVID-19, Vaccine

Emergex, a company focusing on the development of medicines against viral and bacterial infectious diseases, has announced a collaboration and …

News
pfizer_building_logo1

EU states to receive 100m extra doses of Pfizer-BioNTech vaccine

January 4, 2021
Sales and Marketing COVID-19, EU, Pfizer, Vaccine

Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …

News
vaccination

Concern as India approves COVID-19 vaccine before trial completion

January 4, 2021
Sales and Marketing COVID-19, Vaccine

Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …

News
static

Moderna’s COVID-19 vaccine achieves over 90% efficacy in Phase III trial

January 4, 2021
Sales and Marketing COVID-19, Moderna

Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …

News
opaganib-bottle-and-tablets

RedHill announces positive top-line data for COVID-19 pneumonia drug

January 4, 2021
Sales and Marketing COVID-19

RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …

News
astrazeneca-sign

UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine

January 4, 2021
Sales and Marketing AstraZeneca, COVID-19, Vaccine

The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 23, 2020
Research and Development COVID-19, Vaccine

The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …

News

Vicore Pharma study suggests C21 could complement COVID-19 vaccines

December 23, 2020
Research and Development COVID-19, Vicore Pharma

Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025